We are live on ! Find out more
ACP

Acuta Capital Partners Portfolio holdings

AUM $142M
1-Year Est. Return 783.79%
This Fund
S&P 500
This Quarter Est. Return
+13.19%
1 Year Est. Return
+783.79%
3 Year Est. Return
+7,472.18%
5 Year Est. Return
+13,792.16%
10 Year Est. Return
+1,629,663.73%
AUM
$209M
AUM Growth
+$36.3M
Cap. Flow
+$35.6M
Cap. Flow %
17.03%
Top 10 Hldgs %
52.12%
Holding
81
New
22
Increased
17
Reduced
10
Closed
28

Top Buys

Rank Stock Value
1
OLED icon
Universal Display
OLED
+$12.7M
2
TVTX icon
Travere Therapeutics
TVTX
+$7.39M
3
SBBP
Strongbridge Biopharma plc.
SBBP
+$7.03M
4
CEMP
Cempra, Inc.
CEMP
+$6.54M
5
IMMU
Immunomedics Inc
IMMU
+$6.29M

Top Sells

Rank Stock Value
1
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$4.3M
2
BEAT
BioTelemetry, Inc.
BEAT
+$3.79M
3
EXEL icon
Exelixis
EXEL
+$3.76M
4
WBMD
WebMD Health Corp.
WBMD
+$3.17M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$3.09M

Sector Composition

Rank Sector Weight
1 Healthcare 66.18%
2 Technology 7.48%
3 Consumer Discretionary 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALIM
26
DELISTED
Alimera Sciences
ALIM
$2.36M 1.13%
64,955
– –
SGNT
27
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$2.3M 1.1%
144,667
-37,951
-21% -$597K
LJPC
28
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.24M 1.07%
82,920
-39,302
-32% -$1.07M
OXFD
29
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$2.19M 1.05%
190,100
+5,354
+3% +$66.3K
EVDY
30
DELISTED
Everyday Health, Inc.
EVDY
$2.16M 1.03%
+358,347
New +$2.75M
BBW icon
31
Build-A-Bear
BBW
$424M
$2.04M 0.98%
167,109
+14,233
+9% +$209K
PDSB icon
32
PDS Biotechnology
PDSB
$40M
$1.99M 0.95%
+7,940
New +$2.56M
BEAT
33
DELISTED
BioTelemetry, Inc.
BEAT
$1.76M 0.84%
150,322
-299,678
-67% -$3.79M
HTWR
34
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$1.74M 0.83%
+34,587
New +$1.62M
EPIX
35
DELISTED
ESSA Pharma
EPIX
$1.48M 0.71%
16,125
+1,705
+12% +$178K
CUTR
36
DELISTED
Cutera, Inc.
CUTR
$1.46M 0.7%
113,807
-3,114
-3% -$42.2K
RIGL icon
37
Rigel Pharmaceuticals
RIGL
$693M
$1.38M 0.66%
45,606
+25,606
+128% +$776K
PTX
38
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$1.28M 0.61%
43,430
-67,442
-61% -$2.04M
FUN icon
39
Cedar Fair
FUN
$1.8B
$1.2M 0.57%
+21,529
New +$1.2M
DCOY
40
Decoy Therapeutics
DCOY
$2.31M
– –
0
– –
CLVS
41
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
$1.05M 0.5%
+30,000
New +$1.93M
SAGE
42
DELISTED
Sage Therapeutics
SAGE
$984K 0.47%
+16,877
New +$836K
OFIX icon
43
Orthofix Medical
OFIX
$496M
$973K 0.47%
+24,813
New +$927K
THC icon
44
Tenet Healthcare
THC
$20.1B
$861K 0.41%
+28,400
New +$931K
QLTI
45
DELISTED
QLT Inc
QLTI
$801K 0.38%
+301,160
New +$848K
CORV
46
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$669K 0.32%
82,552
-9,845
-11% -$82.1K
CBMX
47
DELISTED
CombiMatrix Corporation
CBMX
$520K 0.25%
47,431
-12,145
-20% -$169K
VNDA icon
48
Vanda Pharmaceuticals
VNDA
$315M
$260K 0.12%
+27,952
New +$279K
AKTX
49
Akari Therapeutics
AKTX
$12.9M
$247K 0.12%
+21
New +$312K
CRDC
50
DELISTED
CARDICA INC COM NEW (DE)
CRDC
$183K 0.09%
118,503
-66,441
-36% -$130K
1
2
3 4

Similar funds

EC
EJF Capital Arlington, Virginia $142M AUM 23.3% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
HA
HFG Advisors Cincinatti, Ohio $142M AUM 16.9% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
KCAM
Kagan Cocozza Asset Management Mickleton, New Jersey $142M AUM 12.02% 1-Year Est. Return

Acuta Capital Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Acuta Capital Partners held 81 positions worth $209M, up 21% from $173M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Acuta Capital Partners deployed $35.6M of net new capital in Q4 2015, opening 22 new positions and adding to 17 existing holdings. Its largest new stake was Universal Display: 287,397 shares worth $15.6M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 74% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was BioTelemetry, Inc., an estimated $3.79M trimmed.

  • Acuta Capital Partners's largest Q4 2015 buy was Universal Display: 287,397 shares worth $15.6M.
  • Acuta Capital Partners added most to Cempra, Inc. in Q4 2015, an estimated $6.54M increase.
  • Acuta Capital Partners's biggest Q4 2015 reduction was BioTelemetry, Inc., cutting an estimated $3.79M.
  • Acuta Capital Partners fully exited Lexicon Pharmaceuticals in Q4 2015, selling an estimated $4.3M.
  • Acuta Capital Partners's ten largest holdings make up 52% of its $209M portfolio in Q4 2015.
  • Acuta Capital Partners opened 22 new positions and closed 28 in Q4 2015.
  • Acuta Capital Partners's portfolio value rose 21% quarter-over-quarter to $209M.

Based on Acuta Capital Partners's 13F filing for Q4 2015, filed 12 Feb 2016.